We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04850599
Brief Title: Isatuximab, Carfilzomib, and Pomalidomide for the Treatment of Relapsed or Refractory Multiple Myeloma

First Submitted : April 14, 2021
First Submitted that Met QC Criteria : April 14, 2021
First Posted : April 20, 2021

Last Update Submitted that Met QC Criteria : June 14, 2022
Last Update Posted : June 16, 2022